Target intelligence / Profile preview

Viral RNA methyltransferase (MTase)

Target
MTase
Molecular classification
Enzyme, Methyltransferase, SAM-dependent methyltransferase, RNA modifying enzyme
01

Overview

Viral methyltransferase enzymes catalyze methyl group transfer from S-adenosylmethionine (SAM) to guanine-N7 and ribose-2'-O positions of the viral RNA cap structure, facilitating mRNA stability, translation, and evasion of the host immune response. These enzymes are structurally related across multiple virus families, typically exhibiting a conserved KDKE catalytic tetrad and SAM-binding fold. They are essential for viral replication and pathogenesis, making them attractive candidates for antiviral drug development. Inhibition of viral methyltransferases leads to defective RNA capping and increased detection by host innate immune sensors, attenuating viral propagation and disease.

Other names
Viral methyltransferaseRNA cap methyltransferaseS-adenosylmethionine-dependent methyltransferaseNS5 methyltransferase (flaviviruses)nsp14/nsp16 methyltransferase (coronaviruses)VP39 methyltransferase (poxviruses)L protein methyltransferase (mononegavirales)
02

Mechanism of action

Competitive inhibition at SAM-binding site Allosteric inhibition of active site Disruption of RNA substrate binding

03

Biological functions

RNA capping (cap formation)RNA methylation (N7 guanine and 2'-O ribose positions)Immune evasion (masks viral RNA from pattern recognition receptors)Promotion of viral protein translationRNA stability
04

Disease associations

Infection (promotes viral replication; involved in pathogenicity)Viral immune evasion and persistencePotential role in disease attenuation if disrupted
05

Safety considerations

Potential off-target effects on host methyltransferases, risking host RNA modificationSpecificity required to avoid toxicity
06

Interacting drugs

No approved drugs, but several experimental inhibitors including sinefungin, SAH analogues, or other small-molecule methyltransferase inhibitors

1 more in the full profile.

07

Biomarkers

Viral RNA cap methylation status (N7 and 2'-O methylation)Interferon response markers (e.g., IFIT1 activation when cap methylation is defective)Upregulation of ISGs in response to poorly capped viral RNA

Beyond the preview

Go deeper on Viral RNA methyltransferase (MTase).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Viral RNA methyltransferase (MTase).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call